These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9086574)
1. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574 [TBL] [Abstract][Full Text] [Related]
2. Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor. Mezquita P; Luna V; Muñoz-Torres M; Torres-Vela E; Lopez-Rodriguez F; Callejas JL; Escobar-Jimenez F Thyroid; 1998 Sep; 8(9):791-4. PubMed ID: 9777751 [TBL] [Abstract][Full Text] [Related]
3. Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids. López-Karpovitch X; Ulloa-Aguirre A; von Eiff C; Hurtado-Monroy R; Alanis A Acta Haematol; 1992; 87(3):148-50. PubMed ID: 1642096 [TBL] [Abstract][Full Text] [Related]
4. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis. Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids. Jakucs J; Pocsay G J Endocrinol Invest; 2006 Jan; 29(1):74-7. PubMed ID: 16553037 [TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy for aplastic anemia--review]. Xu CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years. Cheng Y; Xia XY; Zhang W; Ren L; Tian CF; Liu D; Xue G Front Endocrinol (Lausanne); 2023; 14():1064723. PubMed ID: 36777352 [TBL] [Abstract][Full Text] [Related]
8. Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. Moreb J; Shemesh O; Shilo S; Manor C; Hershko C Acta Haematol; 1983; 69(2):127-31. PubMed ID: 6188311 [TBL] [Abstract][Full Text] [Related]
9. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356 [TBL] [Abstract][Full Text] [Related]
10. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422 [TBL] [Abstract][Full Text] [Related]
11. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure]. Robak T Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375 [TBL] [Abstract][Full Text] [Related]
12. [Severe aplastic anemia as a complication of treatment with metizol]. Swider G; Grzywa M; Zuzak Z Wiad Lek; 1996; 49(7-12):136-9. PubMed ID: 9245107 [TBL] [Abstract][Full Text] [Related]
13. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444 [TBL] [Abstract][Full Text] [Related]
14. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor. Somogyi A; Rosta A; Lang I; Werling K Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317 [TBL] [Abstract][Full Text] [Related]
15. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report. Chien MN; Wang CH; Tsan KW Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):351-5. PubMed ID: 8605651 [TBL] [Abstract][Full Text] [Related]
17. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A; Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466 [TBL] [Abstract][Full Text] [Related]
18. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324 [TBL] [Abstract][Full Text] [Related]
19. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia. Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392 [TBL] [Abstract][Full Text] [Related]
20. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia. Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]